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Abstract The aim of this study is to report our experience
with a novel technique, the hysteroscopic morcellator
(HM), for removal of intrauterine myomas and polyps.
We performed a retrospective study on 315 women
undergoing operative hysteroscopy with the HM in our
university-affiliated teaching hospital. We collected data on
installation and operating times, fluid deficit, peri- and
postoperative complications. In 37 patients undergoing
myomectomy with the HM, mean installation time was
8.7 min, mean operating time, 18.2 min, and median fluid
deficit, 440 mL. Three out of 37 HM procedures were
converted to resectoscopy, related to a type 2 myoma. In
278 patients, mean installation and operating times for
polypectomy with the HM were 7.3 min and 6.6 min,
respectively. All procedures were uneventful. Implementa-
tion of the HM for removal of type 0 and 1 myomas ≤3 cm,
and removal of polyps appears safe and effective.
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Background
The use of hysteroscopic mono- or bipolar instruments is
considered the gold standard in circumstances where
scissors are not successful for removal of intrauterine
lesions (e.g., myomas or polyps) [1, 2]. The choice of a
specific hysteroscopic instrument depends on the origin,
location, as well as the size of the intrauterine lesion [1, 2].
Recently, a novel device, the hysteroscopic morcellator
(HM), became commercially available, using mechanical
cutting to reduce the tumor into small chips and conse-
quently evacuating these chips out of the uterine cavity by
aspiration. The HM has been reported as an effective and
safe new technique to remove intrauterine lesions [3].
Furthermore, it was reported that the HM is a safe and
effective alternative to conventional resectoscopy in both
experienced and inexperienced hands [4]. Results with the
HM in clinical practice have hardly been documented [3,
4]. In this article, we present our retrospective data on the
HM for removal of intrauterine myomas and polyps.
Methods
In our university-affiliated teaching hospital (Catharina
Hospital, Eindhoven, the Netherlands), the HM was
introduced in 2006 for hysteroscopic removal of intrauterine
lesions. Up till that year, resectoscopy had been the standard
procedure. We evaluated the introduction of the HM in
retrospect.
Morcellation was performed with the HM (TRUCLEAR,
Smith & Nephew, Andover, USA; Fig. 1). The HM has a
4-mm blade, consisting of a rigid inner tube which rotates
within an outer tube. The blade is inserted into an
electrically powered control unit which connects to a
handheld motor drive unit. A foot pedal activates the blade
and regulates the direction of rotation of the internal blade
tube. The direction can be oscillating or continuous, with
the optimal number of rotations per minute being 750 or
1,100, respectively. The rotary morcellator is recommended
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for polypectomy, and the reciprocating blade for myomec-
tomy (Fig. 2).
The blade has a window opening at the end with cutting
edges through which tissue is aspirated by means of a
vacuum source. The vacuum source is connected to a
regulator valve with a manometer. The optimal suction
power connected to the inner tube of the HM blade is
200 mmHg. When the inner tube is not activated, the
window opening is locked to prevent active suction of the
distension liquid in order to avoid uterine cavity collapse.
The removed tissue is discharged through the device,
collected in a pouch, and made available for pathology
analysis.
The blade of the HM was introduced into the uterine
cavity through the working channel of a continuous flow
9-mm rigid hysteroscope with 0-degree optic (Smith &
Nephew, Andover, USA). After dilatation of the internal os
of the uterine cervix with Hegar dilators, atraumatic
insertion was accomplished with the use of an obturator
in the outer sheath of the hysteroscope. The working
channel also acts as the inflow channel and the hystero-
scope contains a separate outflow channel. Continuous flow
was used for optimal distension, irrigation, and visibility.
The inflow is pressurized with a peristaltic pump (Smith &
Nephew, Andover, USA) with a maximum pressure setting
of 120 mmHg and a maximum flow setting of 700 mL/min,
similar to standard resectoscopy. The outflow is passive.
Normal saline was used for distension and irrigation of the
uterine cavity. All fluid was collected from the passive
outflow tubing of the hysteroscope as well as from the
vacuum tubing connected to the inner blade, and both
measured volumes were subtracted from the measured
inflow volume resulting in the fluid deficit.
First, we retrospectively describe our results with the
HM—using the reciprocating blade—for removal of type 0
and 1 myomas from 2006 until 2009. We collected
information on time needed to install the equipment,
operating time, fluid deficit, and peri- and postoperative
complications from medical records. Conversion rates to
resectoscopy are mentioned.
Secondly, we report our data for removal of intrauterine
polyps with the HM—using the rotary blade—between
2006 and 2009. We collected data on installation and
operating time, fluid deficit, peri- and postoperative
complications, and conversion rates from medical records.
For both myomas and polyps, the diameter was
measured by ultrasound preoperatively. Patients were
hospitalized in daycare. Procedures were performed under
spinal or general anesthesia, and data on type of anesthesia
are given. All patients received antibiotic prophylaxis with
a single dose of metronidazole 500 mg and cefuroxime
1,500 mg. For all procedures, data on pathology analysis
were available.
Findings
Myomas
Our results for removal of intrauterine myomas with the
HM are summarized in Table 1. We performed this HM
procedure in 37 patients aged 26 to 49 (median 45 years).
The mean myoma diameter was 2.0 cm. A type 0 myoma
was seen in 23 patients (62%), 11 patients had a type 1
myoma (30%), and three patients (8%) had a type 2
myoma. Since the HM can only be used for complete
Fig. 1 The hysteroscopic morcellator
Fig. 2 The rotary and reciprocating blade of the HM
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removal of type 0 and 1 myomas, in the latter three cases
conversion to resectoscopy was necessary. Mean time
needed to install equipment was 8.7 min, and mean
operating time was 18.2 min. The limits for fluid deficit
were respected. Seventy-two percent of the procedures was
performed under spinal anesthesia. No complications
occurred. Pathology analysis confirmed the presence of a
myoma in all cases.
Polyps
We performed this HM procedure in 278 patients aged 23
to 81 (median 47 years; Table 1). The mean diameter was
2.4 cm. In 37 patients (13%), the procedure was part of an
infertility treatment. Mean time to install was 7.3 min, and
mean operating time was 6.6 min. Fluid deficit ranged from
0 mL to 300 mL (median 40 mL). The procedure took place
under spinal anesthesia in 68% of the cases. No complica-
tions occurred. There were no conversions to resectoscopy.
Pathology analysis showed 264 cases of benign intrauterine
polyps, 13 cases of hyperplastic polyps, and in one patient,
the intrauterine lesion appeared to be a placental site
nodule.
Discussion
Few data on the use of the HM have been published so far
[3, 4]. Our results with the HM over a time period of
4 years show that it’s a fast technique for removal of
smaller type 0 and 1 myomas, as well as larger polyps, and
that no complications occurred.
The HM beholds some advantages over monopolar
resectoscopy. The use of saline solution prevents hypona-
tremia, although meticulous measurement is indicated to
prevent excessive absorption and fluid overload. When
using the HM, similar to using bipolar electrosurgical
systems instead of the monopolar resectoscope, there is no
generation of stray currents with consequent risk of
electrical burns [5]. No damage is done to the surrounding
of the intrauterine lesion that needs to be removed, and we
note that with the HM, no gas bubbles arise, in contrast to
resectoscopy. Lethal complications have been described
using hysteroscopic electrosurgery causing air bubbles and
consequent gas embolism [6]. Furthermore, aspiration of
the tissue fragments by the HM ensures a clear view and
tissue is preserved for histological examination. In contrast,
in resectoscopy, tissue fragments can block the hystero-
scopic view and they need to be removed one by one, thus,
making repeated in and out movements necessary, possibly
causing uterine damage, and fragments might be lost.
We do acknowledge certain disadvantages of the HM.
First, the inability to coagulate bleeding vessels encoun-
tered during surgery might be a disadvantage [5]. However,
so far, no significant intraoperative or postoperative
bleeding was documented [3]. In addition, our results show
no evidence of significant bleeding during or after the HM
procedure. Secondly, the HM cannot be used for the
treatment of type 2 submucous fibroids [2]. Therefore,
conversions to resectoscopy might occur when a type 2
myoma is misdiagnosed as a type 1 myoma preoperatively.
Third, in case of larger myomas, the use of the HM can
become quite time consuming. Fourth, in general, the cost
of the disposables (blades and tubings) needed to perform a
HM procedure is higher than that of the material needed for
a hysteroscopic resection. Finally, regional or general
anesthesia is mandatory for the HM procedure as it is
necessary to dilate the cervix up to 8 or 9 mm. In contrast,
data on successful ambulant removal of polyps, sized 2–
4.5 cm [7–10], and submucous and partially intramural
myomas, with a diameter up to 2 cm [7], with Versapoint
(twizzle) have been published.
We report short installation and operating times for
hysteroscopic myomectomy and polypectomy with the HM.
Emanuel et al. report a mean operating time of 16.4 min for
myomectomy and 8.7 min for polypectomy with the HM
[3]. Comparing these data to other hysteroscopic techni-
ques, the HM shows a marked reduction in the time needed
to perform hysteroscopic myomectomy and polypectomy.
Emanuel et al. reported a mean operating time of 42.2 min
for hysteroscopic myomectomy and 30.9 min for poly-
pectomy with the monopolar resectoscope [3]. Preutthipan
et al. reported mean operating times ranging from 20.9 min
to 31.9 min for polypectomy with grasping forceps,
microscissors, electric probe, and resectoscope [11].
Unfortunately, data for our study were retrieved retrospec-
tively, and in our center, no comparable control group was
available for other hysteroscopic techniques. Prospective
studies comparing the HM with, for example, monopolar
resectoscopy are needed to confirm the possible advantages of
Tissue N Age
(years)a
Diameter of
tissue (cm)b
Installation
time (min)b
Operating time
(min)b
Fluid deficit
(mL)a
Type of
myoma
0 1 2
Myoma 37 45 (26–49) 2.0 (0.4) 8.7 (1.4) 18.2 (4.1) 440 (100–890) 23 11 3
Polyp 278 47 (23–81) 2.4 (0.7) 7.3 (2.5) 6.6 (3.3) 40 (0–300) – – –
Table 1 Data on hysteroscopic
myomectomy and polypectomy
with the HM
aValues are median (range)
b Values are mean (SD)
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the HM—such as the reduction of operating time—for
removal of myomas and polyps. One should also retrieve
more long-term follow-up data checking for persistence or
recurrence of intrauterine myomas and polyps. Cost-
effectiveness of the HM also needs to be evaluated.
Conclusion
We conclude that in our experience, the HM is a fast, safe,
and easy method for removal of both smaller type 0 and 1
myomas, as well as polyps. Prospective data are needed to
confirm these findings.
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